PRISM BioLab Co.,Ltd announced that it has raised ¥1,500 million in a round of funding on January 24, 2024. The transaction included participation from new investors Eli Lilly and Company and santec Holdings Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,890 JPY | -0.81% | +0.41% | +58.00% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
4,890 JPY | -0.81% | +0.41% | 376M | ||
766.7 USD | +4.31% | +4.00% | 662B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.00% | 376M | |
+11.65% | 110B | |
-1.86% | 28.8B | |
+15.90% | 22.19B | |
-12.51% | 18.27B | |
-7.70% | 17.5B | |
+15.53% | 15.92B | |
-4.17% | 11.75B | |
-1.88% | 10.61B | |
-4.52% | 9.65B |
- Stock Market
- Equities
- 6777 Stock
- News santec Holdings Corporation
- PRISM BioLab Co.,Ltd announced that it has received ¥1.5 billion in funding from santec Holdings Corporation, Eli Lilly and Company